With no seals or valves, Watson-Marlow peristaltic pumps offer contamination-free pumping and are easy to use. The peristaltic pumps are available with custom configurations for fast delivery and lean manufacturing for applications including irrigation, washing and cooling, vacuum and aspiration, and reagent dilution and sampling.
Zyleris PharmaTech has announced the launch of a new drug development service: high-throughput screening of compound library to identify drug candidates for topical and transdermal delivery.
Nabi Biopharmaceuticals has completed the Phase 1 trial for two of the PentaStaph antigens. Completion of this trial was the final milestone associated with the sale of the PentaStaph vaccine to GlaxoSmithKline.
Thanks to new research, patients infected with cancer-causing HPV may someday have an alternative to surgical and harsh chemical treatments. Scientists report on the development of a protein-based inhibitor that could provide a topical treatment for HPV.
A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.
QRxPharma Limited announced it has completed patient enrolment for Study 022, a Phase 3 trial comparing the tolerability and safety profile of MoxDuo IR to equi-analgesic doses of either morphine or oxycodone alone.
Federal health officials said a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats the majority of patients with the virus in less time than older medicines that have been used for 20 years.
Every other week, 7-year-old twins Addison and Cassidy Hempel have an experimental medicine injected into their spines in hopes of battling a rare, fatal disease. And it's their mom who made that possible.
Drug and medical device maker Hospira Inc. said its net income rose 6 percent in the first quarter on strong sales of new products, including generic versions of the cancer drugs Gemzar and Taxotere.
Medical device maker Medtronic and drugmaker Eli Lilly said they will collaborate on an implantable drug delivery system to treat Parkinson's disease, the debilitating brain disorder that causes tremors and movement problems.
Drugmaker Bristol-Myers Squibb Co., which recently got approval of an important new skin cancer drug but is facing a sharp revenue drop next year, will report first-quarter results before the stock market opens Thursday.
Regeneron Pharmaceuticals Inc. and partner Sanofi-Aventis' potential cancer drug met key goals in a late-stage study focusing on colon cancer patients.
Merck & Co. Inc. said its board of directors approved the buyback of up to $5 billion in common stock for the drug developer's treasury. Overall, the company is now authorized to buy back up to $6.4 billion in common stock.
Health products giant Johnson & Johnson said it will buy U.S.-Swiss medical device maker Synthes Inc. for $21.3 billion, greatly increasing its share of the market for surgical trauma equipment and orthopedic implants.
Sage-N Research, Inc. announced a new API toolkit for developers of proteomics data analysis software. The toolkit will enable software developers to add the power and sensitivity of SORCERER analyses to their existing software packages.